Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Matthias Herz"'
Publikováno v:
Advances in Mechanism Design III ISBN: 9783030835934
Manufacturing engineering is concerned with the application of engineering practices in manufacturing processes and production methods. Continuous optimization of processes, tools as well as machinery and equipment is the key to producing quality pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b7f04f39e51baef9aac6839ea2b415a
https://doi.org/10.1007/978-3-030-83594-1_29
https://doi.org/10.1007/978-3-030-83594-1_29
Publikováno v:
Reduced-Order Modeling (ROM) for Simulation and Optimization ISBN: 9783319753188
An increasing number of disruptive innovations with high economic and social impact shape our digitalizing world. Speed and extending scope of these developments are limited by available tools and paradigms to master exploding complexities. Simulatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97a403f089129a88925b308c038cef03
https://doi.org/10.1007/978-3-319-75319-5_8
https://doi.org/10.1007/978-3-319-75319-5_8
Autor:
Robert R. Henry, L. Durrwell, H. Wu, R. Mingrino, K. Jaekel, M. Andjelkovic, B El Azzouzi, Matthias Herz, John B. Buse
Publikováno v:
Diabetes, Obesity and Metabolism. 17:560-565
Aims To evaluate the potential efficacy, safety and tolerability of aleglitazar as monotherapy or add-on therapy to metformin or to a sulphonylurea (either alone or in combination with metformin). Methods We conducted a pooled analysis of data from t
Autor:
Rachel Bennett, M. Dixon, S. Ekman, Kausik K. Ray, John R. Petrie, John B. Buse, Matthias Herz, M. Bengus, Sreenivasa Rao Kondapally Seshasai
Publikováno v:
Diabetes, Obesity and Metabolism. 17:505-510
Aims To study the short-term cardiovascular effects of the once-weekly glucagon-like peptide-1 receptor agonist taspoglutide. Methods We conducted a meta-analysis of individual-participant data from nine randomized controlled trials in the T-Emerge p
Autor:
Sebastian Schmeisser, Andrea Miccoli, Martin von Bergen, Elisabet Berggren, Albert Braeuning, Wibke Busch, Christian Desaintes, Anne Gourmelon, Roland Grafström, Joshua Harrill, Thomas Hartung, Matthias Herzler, George E.N. Kass, Nicole Kleinstreuer, Marcel Leist, Mirjam Luijten, Philip Marx-Stoelting, Oliver Poetz, Bennard van Ravenzwaay, Rob Roggeband, Vera Rogiers, Adrian Roth, Pascal Sanders, Russell S. Thomas, Anne Marie Vinggaard, Mathieu Vinken, Bob van de Water, Andreas Luch, Tewes Tralau
Publikováno v:
Environment International, Vol 178, Iss , Pp 108082- (2023)
The predominantly animal-centric approach of chemical safety assessment has increasingly come under pressure. Society is questioning overall performance, sustainability, continued relevance for human health risk assessment and ethics of this system,
Externí odkaz:
https://doaj.org/article/f976f541aefc4b4e8d0e30fa3b873d98
Publikováno v:
GAMM-Mitteilungen. 35:191-208
This paper deals with the analytical investigations of a nonstationary Darcy-Nernst-Planck-Poisson-type system which is a mathematical model describing electrolyte solutions. For this nonlinear fully coupled system of partial differential equations w
Autor:
Michael Rabbia, Sunder Mudaliar, Cathy Chognot, Matthias Herz, Robert R. Henry, A. Michael Lincoff
Publikováno v:
The Lancet. 374:126-135
Despite previous reports of potential adverse cardiovascular effects of peroxisome proliferator-activated receptor (PPAR) agonists, the promise for PPAR agonists to positively affect risk of cardiovascular disease in patients with type 2 diabetes is
Autor:
M. Andjelkovic, L. Nosek, Annelie Fischer, Matthias Herz, A. Gastaldelli, Tim Heise, Alin Stirban
Publikováno v:
Diabetes, obesitymetabolism. 18(7)
The present single-centre, randomized, double-blind, placebo-controlled phase II study investigated the effect of the balanced dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on whole-body and liver insulin sensitivity, β-c
Autor:
Matthias Herz, Christopher S Konkoy, Don Johns, M. H. Tan, Jan W. Eriksson, J Halse, Sten Madsbad, J Clausen, J Strand
Publikováno v:
Diabetic Medicine. 21:859-866
This study compared the effects of 52 weeks' treatment with pioglitazone, a thiazolidinedione that reduces insulin resistance, and glibenclamide, on insulin sensitivity, glycaemic control, and lipids in patients with Type 2 diabetes.Patients with Typ
Publikováno v:
Diabetic Medicine. 19:917-923
Aims To ascertain whether pre-meal administration of 50% insulin lispro and 50% neutral protamine lispro (NPL), given as a fixed mixture (Humalog® Mix50™, Eli Lilly) (Mix50), provides satisfactory glycaemic control throughout the day compared with